GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:1905176
|
BP
|
positive regulation of vascular smooth muscle cell dedifferentiation
|
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
|
PDGFB
|
GO:1905206
|
BP
|
positive regulation of hydrogen peroxide-induced cell death
|
Any process that activates or increases the frequency, rate or extent of cell death in response to hydrogen peroxide.
|
RIPK1
|
GO:1905223
|
BP
|
epicardium morphogenesis
|
The developmental process by which an epicardium is generated and organized.
|
TGFBR1
|
GO:1905259
|
BP
|
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to nitrosative stress.
|
DNAJA1
|
GO:1905285
|
BP
|
fibrous ring of heart morphogenesis
|
The developmental process by which a fibrous ring of heart is generated and organized.
|
BMPR1A
|
GO:1905305
|
BP
|
negative regulation of cardiac myofibril assembly
|
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac myofibril assembly.
|
SMAD4
|
GO:1905313
|
BP
|
transforming growth factor beta receptor signaling pathway involved in heart development
|
Any transforming growth factor beta receptor signaling pathway that is involved in heart development.
|
TGFB1
|
GO:1905314
|
BP
|
semi-lunar valve development
|
The process whose specific outcome is the progression of a semi-lunar valve over time, from its formation to the mature structure.
|
BMPR2
|
GO:1905337
|
BP
|
positive regulation of aggrephagy
|
Any process that activates or increases the frequency, rate or extent of aggrephagy.
|
HTT
|
GO:1905342
|
BP
|
positive regulation of protein localization to kinetochore
|
Any process that activates or increases the frequency, rate or extent of protein localization to kinetochore.
|
CENPQ
|
GO:1905408
|
BP
|
negative regulation of creatine transmembrane transporter activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of creatine transmembrane transporter activity.
|
OSR1
|
GO:1905426
|
BP
|
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation
|
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation.
|
CSNK1D,
CSNK1E
|
GO:1990000
|
BP
|
amyloid fibril formation
|
The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. An example of this is seen when human RIP1 and RIP3 kinases form a heterodimeric functional amyloid signaling complex (PMID:22817896).
|
APP,
CD36,
RIPK1
|
GO:1990001
|
BP
|
inhibition of cysteine-type endopeptidase activity involved in apoptotic process
|
Any process that prevents the activation of an inactive cysteine-type endopeptidase involved in an apoptotic process.
|
BIRC5,
NOL3,
XIAP,
BIRC3,
BCL2L12
|
GO:1990029
|
BP
|
vasomotion
|
The rhythmical contraction and relaxation of arterioles, observed as slow and fast waves, with frequencies of 1-2 and 10-20 cpm.
|
GJA5
|
GO:1990035
|
BP
|
calcium ion import into cell
|
The directed movement of calcium ions from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.
|
TRPV1,
TRPV6
|
GO:1990036
|
BP
|
calcium ion import into sarcoplasmic reticulum
|
The directed movement of calcium ions into a sarcoplasmic reticulum.
|
ATP2A2
|
GO:1990051
|
BP
|
activation of protein kinase C activity
|
Any process that initiates the activity of the inactive enzyme protein kinase C.
|
LEP
|
GO:1990086
|
BP
|
lens fiber cell apoptotic process
|
Any apoptotic process in a lens fiber cell. Lens fiber cells are elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
|
TGFBR2,
E2F1,
E2F2
|
GO:1990090
|
BP
|
cellular response to nerve growth factor stimulus
|
A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.
|
ARPC3,
FOXO3,
NTRK1,
APP,
CREB1,
AKT1,
ID1,
CSNK1D,
CSNK1E,
RAP1A,
E2F1,
RAPGEF1,
ACAP2,
MAGI2,
TRPV1,
CDC5L,
CIB1,
KIDINS220
|
GO:1990117
|
BP
|
B cell receptor apoptotic signaling pathway
|
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
|
BAX
|
GO:1990126
|
BP
|
retrograde transport, endosome to plasma membrane
|
The directed movement of membrane-bounded vesicles from endosomes back to the plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins.
|
WASH1,
VPS26A,
RAB11B,
ANKRD27,
VPS35,
VPS29,
ANKRD50
|
GO:1990138
|
BP
|
neuron projection extension
|
Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
AURKA,
IQGAP1,
PLXNA3,
TIAM1,
ALCAM,
POSTN,
NDEL1,
FLRT3,
FLRT1,
EIF2AK4,
IMPACT,
PLXNA1
|
GO:1990144
|
BP
|
intrinsic apoptotic signaling pathway in response to hypoxia
|
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to hypoxia (lowered oxygen tension). Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. The pathway ends when the execution phase of apoptosis is triggered.
|
BNIP3
|
GO:1990145
|
BP
|
maintenance of translational fidelity
|
Suppression of the occurrence of translational errors, such as codon-anticodon mis-paring, during the process of translation of a protein using an mRNA template.
|
CDKAL1
|
GO:1990166
|
BP
|
protein localization to site of double-strand break
|
Any process in which a protein is transported to, or maintained at, a region of a chromosome at which a DNA double-strand break has occurred.
|
SLF2,
SLF1
|
GO:1990168
|
BP
|
protein K33-linked deubiquitination
|
A protein deubiquitination process in which a K33-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is removed from a protein.
|
ZRANB1
|
GO:1990180
|
BP
|
mitochondrial tRNA 3'-end processing
|
The process in which the 3' end of a pre-tRNA molecule is converted to that of a mature tRNA in the mitochondrion.
|
TRNT1
|
GO:1990182
|
BP
|
exosomal secretion
|
The process whereby a membrane-bounded vesicle are released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
|
RAB27A,
RAB11A
|
GO:1990253
|
BP
|
cellular response to leucine starvation
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of leucine.
|
GCN1,
EIF2AK4,
IMPACT
|
GO:1990256
|
BP
|
signal clustering
|
Grouping of multiple copies of a signal at a cellular location. May promote receptor clustering and alter the signal transduction response.
|
SEMA5A
|
GO:1990261
|
BP
|
pre-mRNA catabolic process
|
The chemical reactions and pathways resulting in the breakdown of the unspliced pre-mRNA (pre-messenger RNA).
|
ZPR1
|
GO:1990262
|
BP
|
anti-Mullerian hormone signaling pathway
|
A series of molecular signals initiated by the binding of anti-Mullerian hormone to its receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
AMHR2
|
GO:1990268
|
BP
|
response to gold nanoparticle
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gold nanoparticle stimulus.
|
MPO
|
GO:1990314
|
BP
|
cellular response to insulin-like growth factor stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
TGFB1,
CREB1,
CCNA2,
FBN1
|
GO:1990349
|
BP
|
gap junction-mediated intercellular transport
|
The movement of substances between cells via gap junctions. A gap junction is a fine cytoplasmic channel, found in animal cells, that connects the cytoplasm of one cell to that of an adjacent cell, allowing ions and other molecules to pass freely between the two cells.
|
MIP
|
GO:1990379
|
BP
|
lipid transport across blood brain barrier
|
The directed movement of lipid molecules passing through the blood-brain barrier.
|
MFSD2A
|
GO:1990401
|
BP
|
embryonic lung development
|
The process occurring during the embryonic phase whose specific outcome is the progression of the lung over time, from its formation to the mature structure.
|
PDGFA
|
GO:1990402
|
BP
|
embryonic liver development
|
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
|
TGFB1
|
GO:1990403
|
BP
|
embryonic brain development
|
The process occurring during the embryonic phase whose specific outcome is the progression of the brain over time, from its formation to the mature structure.
|
CTNNB1,
TRA2B,
MED12,
MKS1,
CC2D2A
|
GO:1990414
|
BP
|
replication-born double-strand break repair via sister chromatid exchange
|
The repair of a replication-born double-strand DNA break in which the DNA molecule is repaired using the homologous sequence of the sister chromatid which serves as a template to repair the breaks.
|
RAD51
|
GO:1990416
|
BP
|
cellular response to brain-derived neurotrophic factor stimulus
|
A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a brain-derived neurotrophic factor stimulus.
|
EEF2
|
GO:1990418
|
BP
|
response to insulin-like growth factor stimulus
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
XBP1,
AKT1
|
GO:1990426
|
BP
|
mitotic recombination-dependent replication fork processing
|
Replication fork processing that includes recombination between DNA near the arrested fork and homologous sequences. Proteins involved in homologous recombination are required for replication restart.
|
BRCA2,
RAD51
|
GO:1990428
|
BP
|
miRNA transport
|
The directed movement of microRNA (miRNA) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.
|
HNRNPA2B1
|
GO:1990440
|
BP
|
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress
|
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
|
TP53,
HSPA5,
CEBPB,
ATF3,
ATF4,
ATF6,
DDIT3,
CREB3L1
|
GO:1990441
|
BP
|
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress
|
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
|
PPP1R15A,
JUN
|
GO:1990481
|
BP
|
mRNA pseudouridine synthesis
|
The intramolecular conversion of uridine to pseudouridine in an mRNA molecule.
|
DKC1,
TRUB1
|
GO:1990502
|
BP
|
dense core granule maturation
|
Steps required to transform a dense core granule generated at the trans-Golgi network into a fully formed and transmissible dense core granule. Dense core granule maturation proceeds through clathrin-mediated membrane remodeling events and is essential for efficient processing of cargo within dense core granules as well as for removing factors that might otherwise interfere with dense core granule trafficking and exocytosis.
|
SNX19
|
GO:1990523
|
BP
|
bone regeneration
|
The regrowth of bone following its loss or destruction.
|
POSTN
|
GO:1990539
|
BP
|
fructose import across plasma membrane
|
The directed movement of fructose substance from outside of a cell, across the plasma membrane and into the cytosol.
|
SLC2A5
|
GO:1990569
|
BP
|
UDP-N-acetylglucosamine transmembrane transport
|
The directed movement of UDP-N-acetylglucosamine across a membrane.
|
SLC35A3
|
GO:1990573
|
BP
|
potassium ion import across plasma membrane
|
The directed movement of potassium ions from outside of a cell, across the plasma membrane and into the cytosol.
|
ATP1B1,
ATP1A2
|
GO:1990579
|
BP
|
peptidyl-serine trans-autophosphorylation
|
The phosphorylation of a peptidyl-serine to form peptidyl-O-phospho-L-serine on an identical protein. For example, phosphorylation by the other kinase within a homodimer.
|
ERN1
|
GO:1990592
|
BP
|
protein K69-linked ufmylation
|
A protein ufmylation process in which a polymer of the ubiquitin-like protein UFM1 is formed by linkages between lysine residues at position 69 of the UFM1 monomers, is added to a protein.
|
UFM1,
UBA5
|
GO:1990603
|
BP
|
dark adaptation
|
The process by which the rods of the retina gradually become fully responsive to dim light when no longer exposed to bright light.
|
PAPD4
|
GO:1990614
|
BP
|
mitochondrial magnesium ion transmembrane transport
|
A process in which a magnesium ion is transported from one side of a mitochondrial membrane to the other by means of some agent such as a transporter or pore.
|
MRS2
|
GO:1990637
|
BP
|
response to prolactin
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prolactin stimulus. The anterior pituitary hormone prolactin has a number of roles including being essential for lactation.
|
GNRH1
|
GO:1990641
|
BP
|
response to iron ion starvation
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of iron ion.
|
HAMP,
HFE
|
GO:1990646
|
BP
|
cellular response to prolactin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prolactin stimulus.
|
IL6,
CDC5L
|
GO:1990737
|
BP
|
response to manganese-induced endoplasmic reticulum stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of endoplasmic reticulum stress caused by a manganese stimulus.
|
EIF2S1,
ATF4
|
GO:1990774
|
BP
|
tumor necrosis factor secretion
|
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
HMGB1
|
GO:1990776
|
BP
|
response to angiotensin
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen.
|
CYBB,
IQGAP1
|
GO:1990785
|
BP
|
response to water-immersion restraint stress
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of water immersion while being held immobile.
|
FOXO3,
FOXO4,
MDM2
|
GO:1990791
|
BP
|
dorsal root ganglion development
|
The process whose specific outcome is the progression of a dorsal root ganglion over time, from its formation to the mature structure.
|
CTNNB1
|
GO:1990809
|
BP
|
endoplasmic reticulum tubular network membrane organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum (ER) tubular network membrane.
|
ARL6IP1
|
GO:1990822
|
BP
|
basic amino acid transmembrane transport
|
The directed movement of basic amino acids from one side of a membrane to the other.
|
SLC7A2,
SLC7A7
|
GO:1990828
|
BP
|
hepatocyte dedifferentiation
|
The process in which a hepatocyte (specialized epithelial cell of the liver) loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.
|
HNRNPD
|
GO:1990845
|
BP
|
adaptive thermogenesis
|
The regulated production of heat in response to short term environmental changes, such as stress, diet or reduced temperature.
|
PPARGC1A
|
GO:1990910
|
BP
|
response to hypobaric hypoxia
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension combined with low atmospheric pressure. Hypoxia is defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95% and hypobaric is defined as atmospheric pressure below 0.74 atm (greater than 2,500 m above sea level).
|
HSF1
|
GO:1990911
|
BP
|
response to psychosocial stress
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of exposure to aversive or demanding psychological and social conditions that tax or exceed the behavioral resources of the organism.
|
HSF1
|
GO:1990927
|
BP
|
calcium ion regulated lysosome exocytosis
|
The process of secretion by a cell that results in the release of intracellular molecules contained within a lysosome by fusion of the vesicle with the plasma membrane of a cell, induced by a rise in cytosolic calcium-ion levels.
|
SYT11
|
GO:1990928
|
BP
|
response to amino acid starvation
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.
|
EIF4EBP1
|
GO:1990938
|
BP
|
peptidyl-aspartic acid autophosphorylation
|
The phosphorylation by a protein of one or more of its own aspartate amino acid residues, or an aspartate residue on an identical protein.
|
ATP13A2
|
GO:1990966
|
BP
|
ATP generation from poly-ADP-D-ribose
|
The process of generating ATP in the nucleus from poly-ADP-D-ribose. Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming.
|
PARP1,
NUDT5
|
GO:1990967
|
BP
|
multi-organism toxin transport
|
The directed movement of a toxin into, out of or within a cell, or between cells where two or more organisms of the same or different species are involved.
|
RAB29,
RAB40B
|
GO:1990968
|
BP
|
modulation by host of RNA binding by virus
|
A process in which a host organism modulates the frequency, rate or extent of a viral gene product binding to RNA.
|
NUCKS1
|
GO:1990969
|
BP
|
modulation by host of viral RNA-binding transcription factor activity
|
A process in which a host organism modulates the frequency, rate or extent of the activity of a viral RNA-binding transcription factor.
|
NUCKS1
|
GO:2000001
|
BP
|
regulation of DNA damage checkpoint
|
Any process that modulates the frequency, rate or extent of a DNA damage checkpoint.
|
CUL4A,
CRY1,
RNASEH2B,
RFWD3,
FEM1B
|
GO:2000003
|
BP
|
positive regulation of DNA damage checkpoint
|
Any process that activates or increases the frequency, rate or extent of a DNA damage checkpoint.
|
CCAR2
|
GO:2000005
|
BP
|
negative regulation of metanephric S-shaped body morphogenesis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric S-shaped body morphogenesis.
|
BMP4
|
GO:2000007
|
BP
|
negative regulation of metanephric comma-shaped body morphogenesis
|
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
|
BMP4
|
GO:2000008
|
BP
|
regulation of protein localization to cell surface
|
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
|
TOR1A,
CTNNB1,
RAB11B,
HFE,
GBF1
|
GO:2000009
|
BP
|
negative regulation of protein localization to cell surface
|
Any process that stops, prevents, or reduces the frequency, rate or extent of protein localization to the cell surface.
|
TAX1BP3,
LEPROT,
ACTN2,
GPM6B,
COMMD1,
SNX33,
NEDD4L
|
GO:2000010
|
BP
|
positive regulation of protein localization to cell surface
|
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
|
TNF,
SYNJ2BP,
NRG1,
STX4,
STX3,
ERBB4,
SNX33,
RANGRF
|
GO:2000016
|
BP
|
negative regulation of determination of dorsal identity
|
Any process that stops, prevents, or reduces the frequency, rate or extent of determination of dorsal identity.
|
DDIT3
|
GO:2000017
|
BP
|
positive regulation of determination of dorsal identity
|
Any process that activates or increases the frequency, rate or extent of determination of dorsal identity.
|
CTNNB1,
ACVR1
|
GO:2000020
|
BP
|
positive regulation of male gonad development
|
Any process that activates or increases the frequency, rate or extent of male gonad development.
|
WT1,
SOX9,
SEMA3A,
ZFPM2,
CITED2
|
GO:2000021
|
BP
|
regulation of ion homeostasis
|
Any process that modulates the frequency, rate or extent of ion homeostasis.
|
WNK3,
WNK1
|
GO:2000027
|
BP
|
regulation of organ morphogenesis
|
Any process that modulates the frequency, rate or extent of animal organ morphogenesis.
|
TBX1
|
GO:2000035
|
BP
|
regulation of stem cell division
|
Any process that modulates the frequency, rate or extent of stem cell division.
|
SOX17,
NAP1L2
|
GO:2000036
|
BP
|
regulation of stem cell population maintenance
|
Any process that modulates the frequency, rate or extent of stem cell population maintenance.
|
CNOT1,
CNOT3,
TAL1,
HMGA2,
ELAVL1
|
GO:2000041
|
BP
|
negative regulation of planar cell polarity pathway involved in axis elongation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.
|
SFRP1
|
GO:2000042
|
BP
|
negative regulation of double-strand break repair via homologous recombination
|
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
|
POLQ,
FBXO18,
PARPBP
|
GO:2000043
|
BP
|
regulation of cardiac cell fate specification
|
Any process that modulates the frequency, rate or extent of cardiac cell fate specification.
|
SOX17
|
GO:2000045
|
BP
|
regulation of G1/S transition of mitotic cell cycle
|
Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle.
|
BID,
PSME3,
E2F1,
ID2,
KIF14,
PID1,
PDPN
|
GO:2000048
|
BP
|
negative regulation of cell-cell adhesion mediated by cadherin
|
Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
|
PLG,
EPCAM,
RGCC
|
GO:2000049
|
BP
|
positive regulation of cell-cell adhesion mediated by cadherin
|
Any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
|
FLOT1,
WNT5A
|
GO:2000050
|
BP
|
regulation of non-canonical Wnt signaling pathway
|
Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
|
TIAM1
|
GO:2000052
|
BP
|
positive regulation of non-canonical Wnt signaling pathway
|
Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
|
WNT5A,
CSNK1D,
CSNK1E,
SFRP1,
RSPO3
|